Aroosa Malik, registration number 2225303, was handed a 12-month warning by the General Pharmaceutical Council (GPhC) after prescribing Mounjaro without the appropriate checks while working at an unregulated clinic.
At a hearing on July 16, the GPhC’s investigating committee heard that the pharmacist “relied principally on the information solely provided by screenshots from a non-clinical colleague” within the clinic and did not access patient records when prescribing the “high-risk” weight loss drug.
According to the determination document, Malik also failed to ask for “face-to-face consultations with patients” or obtain details of their physical health to “assess their clinical need for ongoing weight loss treatment”.
Read more: ‘Unacceptable’: Pharmacist warned after falsifying patient records
And she “did not approach” patients’ GPs or “obtain information providing independent confirmation” of their weight loss journey or medical history, it added.
The committee acknowledged that Malik had shown insight and remorse, and had provided an explanation, as well as evidence of completed continuing professional development learning.
But it warned that any prescribing decisions made without face-to-face consultations “should include independent verification of information provided” and only be offered “in regulated settings”.
Read more: Pharmacist warned for supplying POMs ‘without valid prescriptions’
The GPhC said Malik worked as a pharmacist and independent prescriber at an unregulated aesthetic clinic called Skin & Drop in London between April 28, 2025 and May 12, 2025.
It said Malik “did not take proper consideration of the risks” of prescribing “large quantities of weight loss medication to patients who may be vulnerable or at risk of medication abuse or dependence”.
Malik did not “ensure appropriate safety netting” was in place for patients, the regulator added, and details recorded on the prescriptions “did not accurately reflect the entity issuing the prescriptions, nor provide sufficient contact details for the prescriber”.
Read more: Superintendent warned over ‘serious’ governance failures
The committee found that Malik had breached the GPhC’s standards on providing person-centred care, working in partnership with others, using professional judgement and demonstrating leadership.
And it reiterated that high-risk medicines requiring ”ongoing monitoring and management” must not be prescribed without “robust systems and checks” in place to ensure patient safety and maintain confidence in the pharmacy profession.
The warning will be published on the register and available for 12 months.
Read the determination in full here.
